Investor Relations

Press Releases

These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.

Sep 25, 2015

Fibrocell and Intrexon Provide Regulatory Update for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Sep 10, 2015

Intrexon to Participate in J.P. Morgan's 6th Annual All Stars Conference
Sep 8, 2015

Environmentally Friendly Insect Control Solutions Tackle Growing Global Health and Agriculture Problems with Unparalleled Accuracy
Aug 27, 2015

Successful Validation of a New Genetically Engineered Miniature Pig Model
Aug 26, 2015

Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
Aug 21, 2015

Intrexon Prices Public Offering of Common Stock
Aug 20, 2015

Intrexon Announces Proposed Public Offering of Common Stock
Aug 20, 2015

Intrexon Energy Partners and Dominion Enter Exclusive Agreement in Marcellus and Utica Basins to Commercialize Novel Method for Natural Gas Bioconversion to Valuable Isobutanol
Aug 10, 2015

Intrexon Announces Second Quarter and First Half 2015 Financial Results
Aug 10, 2015

Intrexon to Acquire Oxitec, Pioneer of Innovative Insect Control Solutions Addressing Global Challenges
Aug 10, 2015

Intrexon and Synthetic Biologics Enter ECC to Develop Novel Biotherapeutics for Treatment of Phenylketonuria
Aug 3, 2015

Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th
Jul 28, 2015

Oragenics Reports Positive In Vivo Antibiotic Efficacy Data in Critical Animal Study
Jul 21, 2015

Intrexon Augments Management Team
Jul 20, 2015

Fibrocell and Intrexon Announce IND Filing of FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Jul 17, 2015

Intrexon to Present at Upcoming Industrial Biotechnology Conferences
Jun 15, 2015

Intrexon Forms Multi-Year Collaboration with New Dedicated Fund
Jun 10, 2015

Intrexon and Oragenics Expand Collaboration to Pursue Development of Biotherapeutics for the Oral Cavity
Jun 8, 2015

Fibrocell and Intrexon Announce Positive in vitro Pre-Clinical Data for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) at European Society of Human Genetics
Jun 5, 2015

Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares
Jun 2, 2015

Intrexon Announces New Sector Leader
May 28, 2015

Fibrocell and Intrexon Announce Poster Presentation on FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB) at the European Society of Human Genetics Annual Meeting 2015
May 26, 2015

Intrexon to Present at the Jefferies 2015 Global Healthcare Conference
May 11, 2015

Intrexon Announces First Quarter 2015 Financial Results
May 4, 2015

Intrexon to Announce First Quarter 2015 Financial Results on Monday, May 11, 2015

Show per page